These results might partly explain the clinically observed NK-cell dysfunction in patients suffering from leukemia/lymphoma, and suggest that exosomal ligands for NKG2D play crucial roles in tumor-associated NK cells abnormalities. Here, KLRK1 is linked to neoplasm.